Clinical Trials Directory

Trials / Terminated

TerminatedNCT00784602

Observing Pelvic Organ Prolapse Symptoms And Treatment Outcomes

Status
Terminated
Phase
Study type
Observational
Enrollment
301 (actual)
Sponsor
Melissa Fischer, MD · Academic / Other
Sex
Female
Age
21 Years
Healthy volunteers
Not accepted

Summary

To prospectively observe the outcomes of surgical prolapse treatment in terms of urinary, bowel, and sexual function, quality of life, patient satisfaction, cost, and achieving patient determined treatment goals.

Detailed description

Patients meeting the inclusion/exclusion criteria will be identified by reviewing the hospital's surgical boarding list and contacted by phone to obtain informed consent. Once informed consent is obtained, chart review will be conducted here at William Beaumont Hospital and at the physician's office to collect patient information related to their prolapse condition. Prior to surgery, questionnaires will be mailed and completed by the participant and then again at 6 and 12 months after surgery, and then yearly. Questionnaires will assess urinary, bowel, and sexual function, and patient treatment goals, treatment satisfaction, and general health and wellbeing. Completion of the questionnaires will be voluntary, and participants will be followed in this manner until voluntary withdrawal, exclusionary criteria emerge, or death.

Conditions

Timeline

Start date
2008-10-29
Primary completion
2016-08-29
Completion
2016-08-29
First posted
2008-11-04
Last updated
2018-01-03

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00784602. Inclusion in this directory is not an endorsement.